Explore more publications!
Modern Africa Today
Got News to Share?

Modern Africa Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on October 20, 2025

Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer
October 20, 2025

Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer

Indeterminate GlobeNewswire
ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
October 20, 2025

ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025

Indeterminate GlobeNewswire
Maxus Mining Announces Appointment of Robert Eckford as Technical Advisor & Marketing Agreement
October 20, 2025

Maxus Mining Announces Appointment of Robert Eckford as Technical Advisor & Marketing Agreement

Indeterminate GlobeNewswire
Judo Bio Presents Data Demonstrating Sustained, Kidney-Selective Gene Silencing Across Species
October 20, 2025

Judo Bio Presents Data Demonstrating Sustained, Kidney-Selective Gene Silencing Across Species

Indeterminate GlobeNewswire
Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025
October 20, 2025

Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025

Indeterminate GlobeNewswire
Reverba Global Introduces ClinOps G.P.S.™ to Set a New Course for Clinical Trial Execution and Chart a Clearer Path from Protocol to Completion
October 20, 2025

Reverba Global Introduces ClinOps G.P.S.™ to Set a New Course for Clinical Trial Execution and Chart a Clearer Path from Protocol to Completion

Indeterminate GlobeNewswire
Oncotelic to Present at the LD Micro Main Event XIX
October 20, 2025

Oncotelic to Present at the LD Micro Main Event XIX

Indeterminate GlobeNewswire
Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders
October 20, 2025

Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders

Indeterminate GlobeNewswire
Aventis Energy Confirms High-Grade Uranium Mineralization up to 8.10% U₃O₈ at Surface on the Corvo Project
October 20, 2025

Aventis Energy Confirms High-Grade Uranium Mineralization up to 8.10% U₃O₈ at Surface on the Corvo Project

Indeterminate GlobeNewswire
Altimmune to Present Phase 2b IMPACT Data on Pemvidutide in MASH in Late-Breaking Oral Podium Presentation and Late-Breaking Poster at AASLD The Liver Meeting® 2025
October 20, 2025

Altimmune to Present Phase 2b IMPACT Data on Pemvidutide in MASH in Late-Breaking Oral Podium Presentation and Late-Breaking Poster at AASLD The Liver Meeting® 2025

Indeterminate GlobeNewswire
CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance
October 20, 2025

CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance

Indeterminate GlobeNewswire
Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt
October 20, 2025

Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt

Indeterminate GlobeNewswire
New One-Year Data Reinforcing the Robust and Sustained Efficacy of EMPAVELI® (pegcetacoplan) in C3G and Primary IC-MPGN to be Presented at ASN Kidney Week
October 20, 2025

New One-Year Data Reinforcing the Robust and Sustained Efficacy of EMPAVELI® (pegcetacoplan) in C3G and Primary IC-MPGN to be Presented at ASN Kidney Week

Indeterminate GlobeNewswire
Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
October 20, 2025

Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma

Indeterminate GlobeNewswire
Medicenna Therapeutics Announces Participation in Upcoming Conferences
October 20, 2025

Medicenna Therapeutics Announces Participation in Upcoming Conferences

Indeterminate GlobeNewswire
BPGbio and Icahn School of Medicine at Mount Sinai Publish Landmark Study on the Living Human Brain, Unlocking New Molecular Insights Into Neurodegenerative Disease
October 20, 2025

BPGbio and Icahn School of Medicine at Mount Sinai Publish Landmark Study on the Living Human Brain, Unlocking New Molecular Insights Into Neurodegenerative Disease

Indeterminate GlobeNewswire
BioCryst to Report Third Quarter 2025 Financial Results on November 3
October 20, 2025

BioCryst to Report Third Quarter 2025 Financial Results on November 3

Indeterminate GlobeNewswire
US Federal Government Selects Headwater Gold’s Spring Peak Project for FAST-41 Permitting Track
October 20, 2025

US Federal Government Selects Headwater Gold’s Spring Peak Project for FAST-41 Permitting Track

Indeterminate GlobeNewswire
Titan Mining Finds Significant Concentrations of Germanium at its Empire State Mine in New York
October 20, 2025

Titan Mining Finds Significant Concentrations of Germanium at its Empire State Mine in New York

Indeterminate GlobeNewswire
Keros Therapeutics Commences Issuer Tender Offer to Repurchase up to $194.4 Million Shares
October 20, 2025

Keros Therapeutics Commences Issuer Tender Offer to Repurchase up to $194.4 Million Shares

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions